InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Kelly, Jared Ryan. Director active across 1 company, notably Oncolytics Biotech Inc.. Cumulatively, 1 filings have been recorded. Activity tracked since 1 June 2026. The latest transaction was disclosed on 1 June 2026 (50 - Grant of options). Regulator: SEDI. All data is free.
1 of 1 declaration